Biopharmaceutical company Zymeworks Inc. (NYSE: ZYME) has received a takeover approach and is working with an investment bank
https://www.streetinsider.com/Hot+M+and+A/Zymeworks+%28ZYME%29+Explores+Potential+Sale+Following+Takeover+Approach+-+Source/18633227.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.